BRIEF-Ironwood, AstraZeneca enter U.S. licensing agreement for lesinurad By: Reuters: Company News April 26, 2016 at 05:20 AM EDT * Ironwood Pharmaceuticals enters into U.S. licensing agreement with AstraZeneca for Lesinurad Read More >> Related Stocks: Astrazeneca Plc ADR Ironwood Pharmaceuti